Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017, Article ID 1917804, 9 pages
https://doi.org/10.1155/2017/1917804
Research Article

JAK2/STAT3 Pathway Was Associated with the Protective Effects of IL-22 On Aortic Dissection with Acute Lung Injury

1Department of Cardiovascular Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, China
2Hubei Key Laboratory of Cardiology, Wuhan 430060, China

Correspondence should be addressed to Zhiwei Wang; nc.ude.uhw@iewihzgnaw and Zhiyong Wu; moc.anis@988uwgnoyihz

Received 15 January 2017; Revised 24 March 2017; Accepted 5 April 2017; Published 30 July 2017

Academic Editor: Stamatios E. Theocharis

Copyright © 2017 Wei Ren et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Talla, A. A. Dmytriw, and E. Nguyen, “Acute type A aortic dissection with mediastinal hematoma mimicking massive pulmonary embolus,” The International Journal of Cardiovascular Imaging, vol. 33, no. 2, pp. 259-260, 2017. View at Google Scholar
  2. Z. Wu, F. Dai, W. Ren, H. Liu, B. Li, and J. Chang, “Angiotensin II induces apoptosis of human pulmonary microvascular endothelial cells in acute aortic dissection complicated with lung injury patients through modulating the expression of monocyte chemoattractant protein-1,” American Journal of Translational Research, vol. 8, no. 1, pp. 28–36, 2016. View at Google Scholar
  3. Z. Wu, Y. Ruan, J. Chang, B. Li, and W. Ren, “Angiotensin II is related to the acute aortic dissection complicated with lung injury through mediating the release of MMP9 from macrophages,” American Journal of Translational Research, vol. 8, no. 3, pp. 1426–1436, 2016. View at Google Scholar
  4. L. Dumoutier, J. Louahed, and J. C. Renauld, “Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9,” Journal of Immunology, vol. 164, no. 4, pp. 1814–1819, 2000. View at Google Scholar
  5. H. Benham, P. Norris, J. Goodall et al., “Th17 and Th22 cells in psoriatic arthritis and psoriasis,” Arthritis Research & Therapy, vol. 15, no. 5, p. R136, 2013. View at Google Scholar
  6. L. Zhao, Z. Jiang, Y. Jiang et al., “IL-22+ CD4+ T cells in patients with rheumatoid arthritis,” International Journal of Rheumatic Diseases, vol. 16, no. 5, pp. 518–526, 2013. View at Google Scholar
  7. J. Lin, L. H. Yue, and W. Q. Chen, “Decreased plasma IL-22 levels and correlations with IL-22-producing T helper cells in patients with new-onset systemic lupus erythematosus,” Scandinavian Journal of Immunology, vol. 79, no. 2, pp. 131–136, 2014. View at Google Scholar
  8. O. N. Bae, S. Ahn, S. H. Jin et al., “Chemical allergens stimulate human epidermal keratinocytes to produce lymphangiogenic vascular endothelial growth factor,” Toxicology and Applied Pharmacology, vol. 283, no. 2, pp. 147–155, 2015. View at Google Scholar
  9. W. G. Ma, J. Zheng, S. B. Dong et al., “Sun’s procedure of total arch replacement using a tetrafurcated graft with stented elephant trunk implantation: analysis of early outcome in 398 patients with acute type A aortic dissection,” Annals of Cardiothoracic Surgery, vol. 2, no. 5, pp. 621–628, 2013. View at Google Scholar
  10. L. Sun, R. Qi, J. Zhu, Y. Liu, Q. Chang, and J. Zheng, “Repair of acute type A dissection: our experiences and results,” The Annals of Thoracic Surgery, vol. 91, no. 4, pp. 1147–1152, 2011. View at Google Scholar
  11. F. del Porto, M. Proietta, L. Tritapepe et al., “Inflammation and immune response in acute aortic dissection,” Annals of Medicine, vol. 42, no. 8, pp. 622–629, 2010. View at Google Scholar
  12. S. Han and R. K. Mallampalli, “Correction: the acute respiratory distress syndrome: from mechanism to translation,” Journal of Immunology, vol. 194, no. 11, p. 5569, 2015. View at Google Scholar
  13. M. Bhargava and C. H. Wendt, “Biomarkers in acute lung injury,” Translational Research, vol. 159, no. 4, pp. 205–217.
  14. X. Bai, L. Fan, T. He et al., “SIRT1 protects rat lung tissue against severe burn-induced remote ALI by attenuating the apoptosis of PMVECs via p38 MAPK signaling,” Scientific Reports, vol. 5, p. 10277, 2015. View at Google Scholar
  15. H. Zhang and G. Y. Sun, “Expression and regulation of AT1 receptor in rat lung microvascular endothelial cell,” The Journal of Surgical Research, vol. 134, no. 2, pp. 190–197, 2006. View at Google Scholar
  16. J. Deng, D. X. Wang, W. Deng, C. Y. Li, and J. Tong, “The effect of endogenous angiotensin II on alveolar fluid clearance in rats with acute lung injury,” Canadian Respiratory Journal, vol. 19, no. 5, pp. 311–318, 2012. View at Google Scholar
  17. H. Zhang and G. Y. Sun, “LPS induces permeability injury in lung microvascular endothelium via AT(1) receptor,” Archives of Biochemistry and Biophysics, vol. 441, no. 1, pp. 75–83, 2005. View at Google Scholar
  18. M. Podowski, C. Calvi, S. Metzger et al., “Angiotensin receptor blockade attenuates cigarette smoke-induced lung injury and rescues lung architecture in mice,” The Journal of Clinical Investigation, vol. 122, no. 1, pp. 229–240, 2012. View at Google Scholar
  19. S. Supe, F. Kohse, F. Gembardt, W. M. Kuebler, and T. Walther, “Therapeutic time window for angiotensin-(1-7) in acute lung injury,” British Journal of Pharmacology, vol. 173, no. 10, pp. 1618–1628, 2016. View at Google Scholar
  20. S. L. Della Penna, G. Cao, N. M. Kouyoumdzian et al., “Role of angiotensin II and oxidative stress on renal aquaporins expression in hypernatremic rats,” Journal of Physiology and Biochemistry, vol. 70, no. 2, pp. 465–478, 2011. View at Google Scholar
  21. K. W. Kim, H. R. Kim, J. Y. Park et al., “Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts,” Arthritis and Rheumatism, vol. 64, no. 4, pp. 1015–1023, 2012. View at Google Scholar
  22. L. A. Zenewicz and R. A. Flavell, “Recent advances in IL-22 biology,” International Immunology, vol. 23, no. 3, pp. 159–163, 2011. View at Google Scholar
  23. K. Wolk, E. Witte, K. Witte, K. Warszawska, and R. Sabat, “Biology of interleukin-22,” Seminars in Immunopathology, vol. 32, no. 1, pp. 17–31, 2010. View at Google Scholar
  24. R. Sabat, W. Ouyang, and K. Wolk, “Therapeutic opportunities of the IL-22-IL-22R1 system,” Nature Reviews. Drug Discovery, vol. 13, no. 1, pp. 21–38, 2014. View at Google Scholar
  25. R. Savan, A. P. McFarland, D. A. Reynolds et al., “A novel role for IL-22R1 as a driver of inflammation,” Blood, vol. 117, no. 2, pp. 575–584, 2011. View at Google Scholar
  26. Q. Xia, X. Xiang, S. Patel, R. Puranik, Q. Xie, and S. Bao, “Characterisation of IL-22 and interferon-gamma-inducible chemokines in human carotid plaque,” International Journal of Cardiology, vol. 154, no. 2, pp. 187–189, 2012. View at Google Scholar
  27. S. Rattik, K. Hultman, U. Rauch et al., “IL-22 affects smooth muscle cell phenotype and plaque formation in apolipoprotein E knockout mice,” Atherosclerosis, vol. 242, no. 2, pp. 506–514, 2015. View at Google Scholar
  28. G. F. Sonnenberg, L. A. Fouser, and D. Artis, “Functional biology of the IL-22-IL-22R pathway in regulating immunity and inflammation at barrier surfaces,” Advances in Immunology, vol. 107, pp. 1–29, 2010. View at Google Scholar
  29. Z. Lu, R. Liu, E. Huang, and Y. Chu, “MicroRNAs: new regulators of IL-22,” Cellular Immunology, vol. 304-305, pp. 1–8, 2011. View at Google Scholar
  30. Y. Yang, W. Duan, Z. Jin et al., “JAK2/STAT3 activation by melatonin attenuates the mitochondrial oxidative damage induced by myocardial ischemia/reperfusion injury,” Journal of Pineal Research, vol. 55, no. 3, pp. 275–286, 2013. View at Google Scholar
  31. G. E. Cambi, G. Lucchese, M. M. Djeokeng et al., “Impaired JAK2-induced activation of STAT3 in failing human myocytes,” Molecular BioSystems, vol. 8, no. 9, pp. 2351–2359, 2012. View at Google Scholar
  32. L. Wang, L. Zhuang, H. Rong et al., “MicroRNA-101 inhibits proliferation of pulmonary microvascular endothelial cells in a rat model of hepatopulmonary syndrome by targeting the JAK2/STAT3 signaling pathway,” Molecular Medicine Reports, vol. 12, no. 6, pp. 8261–8267, 2015. View at Google Scholar
  33. Y. Moriwaki, K. Takada, T. Nagasaki et al., “IL-22/STAT3-induced increases in SLURP1 expression within psoriatic lesions exerts antimicrobial effects against Staphylococcus aureus,” PloS One, vol. 10, no. 10, article e0140750, 2015. View at Google Scholar
  34. D. Chen, J. Liu, B. Rui et al., “GSTpi protects against angiotensin II-induced proliferation and migration of vascular smooth muscle cells by preventing signal transducer and activator of transcription 3 activation,” Biochimica et Biophysica Acta, vol. 1843, no. 2, pp. 454–463, 2014. View at Google Scholar
  35. M. Leifheit-Nestler, N. M. Wagner, R. Gogiraju et al., “Importance of leptin signaling and signal transducer and activator of transcription-3 activation in mediating the cardiac hypertrophy associated with obesity,” Journal of Translational Medicine, vol. 11, p. 170, 2013. View at Google Scholar
  36. P. Yue, F. Lopez-Tapia, D. Paladino et al., “Hydroxamic acid and benzoic acid-based STAT3 inhibitors suppress human glioma and breast cancer phenotypes in vitro and in vivo,” Cancer Research, vol. 76, no. 3, pp. 652–663, 2016. View at Google Scholar
  37. A. Rohini, N. Agrawal, C. N. Koyani, and R. Singh, “Molecular targets and regulators of cardiac hypertrophy,” Pharmacological Research, vol. 61, no. 4, pp. 269–280, 2010. View at Google Scholar
  38. H. Y. Luo, K. J. Hu, J. Y. Zhou, and C. S. Wang, “Analysis of the risk factors of postoperative respiratory dysfunction of type A aortic dissection and lung protection,” Perfusion, vol. 24, no. 3, pp. 199–202, 2009. View at Google Scholar